Association between a four-parameter inflammatory index and all-cause mortality in critical ill patients with non-traumatic subarachnoid hemorrhage: a retrospective analysis of the MIMIC-IV database (2012-2019)

医学 重症监护室 倾向得分匹配 蛛网膜下腔出血 比例危险模型 内科学 回顾性队列研究 人口 危险系数 混淆 创伤性脑损伤 冲程(发动机) 生存分析 机械工程 置信区间 环境卫生 精神科 工程类
作者
Yongwei Huang,Ye Zhang,Zongping Li,Xiao-Shuang Yin
出处
期刊:Frontiers in Immunology [Frontiers Media SA]
卷期号:14 被引量:5
标识
DOI:10.3389/fimmu.2023.1235266
摘要

Non-traumatic subarachnoid hemorrhage (SAH), primarily due to the rupture of intracranial aneurysms, contributes significantly to the global stroke population. A novel biomarker, pan-immune-inflammation value (PIV) or called the aggregate index of systemic inflammation (AISI), linked to progression-free survival and overall survival in non-small-cell lung cancer and mortality in Coronavirus Disease 2019 (COVID-19) patients, has surfaced recently. Its role in non-traumatic SAH patients, however, remains under-researched. This study aims to determine the relationship between PIV and all-cause mortality in non-traumatic SAH patients.A retrospective analysis was conducted using data from the Medical Information Mart for Intensive Care (MIMIC-IV) database to examine the association between PIV and all-cause mortality in critically ill patients with non-traumatic SAH. PIV measurements were collected at Intensive Care Unit (ICU) admission, and several mortality measures were examined. To control for potential confounding effects, a 1:1 propensity score matching (PSM) method was applied. The optimal PIV cutoff value was identified as 1362.45 using X-tile software that is often used to calculate the optimal cut-off values in survival analysis and continuous data of medical or epidemiological research. The relationship between PIV and short- and long-term all-cause mortality was analyzed using a multivariate Cox proportional hazard regression model and Kaplan-Meier (K-M) survival curve analysis. Interaction and subgroup analyses were also carried out.The study included 774 non-traumatic SAH patients. After PSM, 241 pairs of score-matched patients were generated. The Cox proportional hazard model, adjusted for potential confounders, found a high PIV (≥ 1362.45) independently associated with 90-day all-cause mortality both pre- (hazard ratio [HR]: 1.67; 95% confidence intervals (CI): 1.05-2.65; P = 0.030) and post-PSM (HR: 1.58; 95% CI: 1.14-2.67; P = 0.042). K-M survival curves revealed lower 90-day survival rates in patients with PIV ≥ 1362.45 before (31.1% vs. 16.1%%, P < 0.001) and after PSM (68.9% vs. 80.9%, P < 0.001). Similarly, elevated PIV were associated with increased risk of ICU (pre-PSM: HR: 2.10; 95% CI: 1.12-3.95; P = 0.02; post-PSM: HR: 2.33; 95% CI: 1.11-4.91; P = 0.016), in-hospital (pre-PSM: HR: 1.91; 95% CI: 1.12-3.26; P = 0.018; post-PSM: 2.06; 95% CI: 1.10-3.84; P = 0.034), 30-day (pre-PSM: HR: 1.69; 95% CI: 1.01-2.82; P = 0.045; post-PSM: 1.66; 95% CI: 1.11-2.97; P = 0.047), and 1-year (pre-PSM: HR: 1.58; 95% CI: 1.04-2.40; P = 0.032; post-PSM: 1.56; 95% CI: 1.10-2.53; P = 0.044) all-cause mortality. The K-M survival curves confirmed lower survival rates in patients with higher PIV both pre- and post PSM for ICU (pre-PSM: 18.3% vs. 8.4%, P < 0.001; post-PSM:81.7 vs. 91.3%, P < 0.001), in-hospital (pre-PSM: 25.3% vs. 12.8%, P < 0.001; post-PSM: 75.1 vs. 88.0%, P < 0.001), 30-day (pre-PSM: 24.9% vs. 11.4%, P < 0.001; post-PSM:74.7 vs. 86.3%, P < 0.001), and 1-year (pre-PSM: 36.9% vs. 20.8%, P < 0.001; P = 0.02; post-PSM: 63.1 vs. 75.1%, P < 0.001) all-cause mortality. Stratified analyses indicated that the relationship between PIV and all-cause mortality varied across different subgroups.In critically ill patients suffering from non-traumatic SAH, an elevated PIV upon admission correlated with a rise in all-cause mortality at various stages, including ICU, in-hospital, the 30-day, 90-day, and 1-year mortality, solidifying its position as an independent mortality risk determinant. This study represents an attempt to bridge the current knowledge gap and to provide a more nuanced understanding of the role of inflammation-based biomarkers in non-traumatic SAH. Nevertheless, to endorse the predictive value of PIV for prognosticating outcomes in non-traumatic SAH patients, additional prospective case-control studies are deemed necessary.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
坦率发布了新的文献求助10
1秒前
噜咔完成签到 ,获得积分10
2秒前
开心听露发布了新的文献求助10
2秒前
车到山前必有路女士完成签到,获得积分10
3秒前
4秒前
Felix完成签到,获得积分10
4秒前
lin发布了新的文献求助20
5秒前
ss发布了新的文献求助30
5秒前
benben应助nuliguan采纳,获得10
5秒前
小巧蛋挞发布了新的文献求助10
6秒前
7秒前
7秒前
8秒前
脑洞疼应助sweat采纳,获得10
9秒前
All is well完成签到,获得积分10
10秒前
伈X发布了新的文献求助10
10秒前
Qyelty完成签到,获得积分10
10秒前
najibveto应助zzznznnn采纳,获得10
10秒前
MIMIXUAN完成签到,获得积分10
11秒前
11秒前
领导范儿应助开心听露采纳,获得10
13秒前
参数估计完成签到,获得积分10
15秒前
Rukia完成签到,获得积分10
15秒前
大模型应助电池高手采纳,获得10
15秒前
15秒前
wakeeeeeee完成签到,获得积分10
15秒前
鱼香丸子完成签到,获得积分10
16秒前
blue发布了新的文献求助10
16秒前
Maestro_S应助十八采纳,获得20
16秒前
16秒前
超级无敌暴龙战士完成签到,获得积分10
17秒前
英俊的铭应助动人的铃铛采纳,获得10
17秒前
星辰大海应助小巧蛋挞采纳,获得10
17秒前
情怀应助暴躁的信封采纳,获得10
18秒前
瘦瘦含芙完成签到,获得积分10
19秒前
体贴电源完成签到,获得积分10
19秒前
19秒前
WKK完成签到,获得积分10
19秒前
洋芋完成签到,获得积分10
20秒前
高分求助中
Evolution 10000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 600
Distribution Dependent Stochastic Differential Equations 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3157055
求助须知:如何正确求助?哪些是违规求助? 2808405
关于积分的说明 7877451
捐赠科研通 2466898
什么是DOI,文献DOI怎么找? 1313069
科研通“疑难数据库(出版商)”最低求助积分说明 630364
版权声明 601919